BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

899 related articles for article (PubMed ID: 26751635)

  • 21. Stem cell treatment in Amyotrophic Lateral Sclerosis.
    Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Nasuelli N; Oggioni GD; Testa L; Fagioli F
    J Neurol Sci; 2008 Feb; 265(1-2):78-83. PubMed ID: 17582439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis.
    Siwek T; Jezierska-Woźniak K; Maksymowicz S; Barczewska M; Sowa M; Badowska W; Maksymowicz W
    Med Sci Monit; 2020 Dec; 26():e927484. PubMed ID: 33301428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study.
    Prabhakar S; Marwaha N; Lal V; Sharma RR; Rajan R; Khandelwal N
    Neurol India; 2012; 60(5):465-9. PubMed ID: 23135021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study.
    Huang H; Chen L; Xi H; Wang H; Zhang J; Zhang F; Liu Y
    Clin Transplant; 2008; 22(6):710-8. PubMed ID: 18673377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.
    Gordon PH; Moore DH; Miller RG; Florence JM; Verheijde JL; Doorish C; Hilton JF; Spitalny GM; MacArthur RB; Mitsumoto H; Neville HE; Boylan K; Mozaffar T; Belsh JM; Ravits J; Bedlack RS; Graves MC; McCluskey LF; Barohn RJ; Tandan R;
    Lancet Neurol; 2007 Dec; 6(12):1045-53. PubMed ID: 17980667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis.
    Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Boccaletti R; Testa L; Livigni S; Fagioli F
    Neurol Res; 2006 Jul; 28(5):523-6. PubMed ID: 16808883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?
    Coatti GC; Beccari MS; Olávio TR; Mitne-Neto M; Okamoto OK; Zatz M
    Cytometry A; 2015 Mar; 87(3):197-211. PubMed ID: 25645594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is cell-based therapy more efficacious for people with amyotrophic lateral sclerosis/motor neuron disease than placebo or no treatment? - A Cochrane review summary with commentary.
    Ceravolo MG
    NeuroRehabilitation; 2020; 46(4):613-615. PubMed ID: 32538885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study.
    Mazzini L; Mareschi K; Ferrero I; Miglioretti M; Stecco A; Servo S; Carriero A; Monaco F; Fagioli F
    Cytotherapy; 2012 Jan; 14(1):56-60. PubMed ID: 21954839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Use of Autologous Mesenchymal Stem Cells for Cell Therapy of Patients with Amyotrophic Lateral Sclerosis in Belarus.
    Rushkevich YN; Kosmacheva SM; Zabrodets GV; Ignatenko SI; Goncharova NV; Severin IN; Likhachev SA; Potapnev MP
    Bull Exp Biol Med; 2015 Aug; 159(4):576-81. PubMed ID: 26395626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility, safety, and preliminary proof of principles of autologous neural stem cell treatment combined with T-cell vaccination for ALS patients.
    Moviglia GA; Moviglia-Brandolino MT; Varela GS; Albanese G; Piccone S; Echegaray G; Martinez G; Blasseti N; Farias J; Farina P; Perusso A; Gaeta CA
    Cell Transplant; 2012; 21 Suppl 1():S57-63. PubMed ID: 22507681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.
    Uccelli A; Laroni A; Brundin L; Clanet M; Fernandez O; Nabavi SM; Muraro PA; Oliveri RS; Radue EW; Sellner J; Soelberg Sorensen P; Sormani MP; Wuerfel JT; Battaglia MA; Freedman MS;
    Trials; 2019 May; 20(1):263. PubMed ID: 31072380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Efficacy and Safety of Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis: A Pilot Study.
    Shamsaei G; Houshmand F; Ahmadzadeh Deylami A; Valizadeh A; Rafie S; Moradi M
    Adv Pharm Bull; 2023 Mar; 13(2):361-367. PubMed ID: 37342380
    [No Abstract]   [Full Text] [Related]  

  • 34. Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis.
    Andrews JA; Meng L; Kulke SF; Rudnicki SA; Wolff AA; Bozik ME; Malik FI; Shefner JM
    JAMA Neurol; 2018 Jan; 75(1):58-64. PubMed ID: 29181534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplantation of mesenchymal stem cells in ALS.
    Mazzini L; Vercelli A; Ferrero I; Boido M; Cantello R; Fagioli F
    Prog Brain Res; 2012; 201():333-59. PubMed ID: 23186722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial).
    Morimoto S; Takahashi S; Fukushima K; Saya H; Suzuki N; Aoki M; Okano H; Nakahara J
    Regen Ther; 2019 Dec; 11():143-166. PubMed ID: 31384636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.
    Cudkowicz ME; van den Berg LH; Shefner JM; Mitsumoto H; Mora JS; Ludolph A; Hardiman O; Bozik ME; Ingersoll EW; Archibald D; Meyers AL; Dong Y; Farwell WR; Kerr DA;
    Lancet Neurol; 2013 Nov; 12(11):1059-67. PubMed ID: 24067398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke.
    Lee JS; Hong JM; Moon GJ; Lee PH; Ahn YH; Bang OY;
    Stem Cells; 2010 Jun; 28(6):1099-106. PubMed ID: 20506226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope?
    Allers C; Jones JA; Lasala GP; Minguell JJ
    Regen Med; 2014; 9(5):637-47. PubMed ID: 25372079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cell transplantation into the intraventricular space via an Ommaya reservoir in a patient with amyotrophic lateral sclerosis.
    Baek W; Kim YS; Koh SH; Lim SW; Kim HY; Yi HJ; Kim H
    J Neurosurg Sci; 2012 Sep; 56(3):261-3. PubMed ID: 22854595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.